AbbVie Inc.’s TV advertisements featuring tennis legend Serena Williams make misleading claims about the effectiveness of its ...

In the ad for oral CGRP inhibitor Ubrelvy (ubrogepant), Williams is depicted as suffering from a migraine while in a talk ...

The Food and Drug Administration recently intervened regarding a migraine medication ad featuring tennis superstar Serena ...

The FDA has scolded AbbVie for making false and misleading claims about a TV ad about a migraine pill that features Serena ...

The FDA has faulted AbbVie’s promotion of the migraine drug Ubrelvy, calling the company out for an ad featuring Serena ...

A drugmaker's advertisement featuring Serena Williams is under FDA scrutiny for misleading claims that it can quickly cure ...

The Food and Drug Administration cited AbbVie for making misleading claims about a migraine pill in TV ads featuring tennis ...

The U.S. Food and Drug Administration is taking North Chicago-based drugmaker AbbVie to task, warning in a recent letter that ...

Today's health news includes the FDA's probing into metal in tampons and scolding Abbvie for a 'misleading' Serena Williams ad.

The FDA's Office of Prescription Drug Promotion sent a letter to AbbVie late last month, calling out the company for what it ...

AbbVie's TV spots say that all patients who take the drug, called Ubrelvy, can expect their migraine pain to be eliminated ...